251 related articles for article (PubMed ID: 23806007)
21. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
Foote RL; Molina JR; Kasperbauer JL; Lloyd RV; McIver B; Morris JC; Grant CS; Thompson GB; Richards ML; Hay ID; Smallridge RC; Bible KC
Thyroid; 2011 Jan; 21(1):25-30. PubMed ID: 21162687
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report.
Liu J; Cui N; Ding W; Dong X; Chen X; Jiang J; Liu Y
Diagn Pathol; 2020 Jul; 15(1):89. PubMed ID: 32693811
[TBL] [Abstract][Full Text] [Related]
26. Expression, regulation, and function of paired-box gene 8 in the human placenta and placental cancer cell lines.
Ferretti E; Arturi F; Mattei T; Scipioni A; Tell G; Tosi E; Presta I; Morisi R; Lacroix L; Gulino A; Russo D; Damante G; Filetti S
Endocrinology; 2005 Sep; 146(9):4009-15. PubMed ID: 15961562
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract][Full Text] [Related]
28. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
Schmitt AC; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
[TBL] [Abstract][Full Text] [Related]
29. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
[TBL] [Abstract][Full Text] [Related]
30. Significant immunohistochemical expression of human chorionic gonadotropin in high-grade osteosarcoma is rare, but may be associated with clinically elevated serum levels.
Lee AF; Pawel BR; Sullivan LM
Pediatr Dev Pathol; 2014; 17(4):278-85. PubMed ID: 24856811
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis.
Capron T; Giusiano S; Bourinet V; Laroumagne S; Dutau H; Astoul P
Thorac Cancer; 2019 Nov; 10(11):2175-2178. PubMed ID: 31529678
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic thyroid carcinoma with long term survival after combined treatment: case report.
Kurukahvecioglu O; Ege B; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2007 Mar; 41(1):41-4. PubMed ID: 17437344
[TBL] [Abstract][Full Text] [Related]
33. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
Pacheco-Ojeda LA; Martínez AL; Alvarez M
Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
[TBL] [Abstract][Full Text] [Related]
35. Time trend in tumour size and characteristics of anaplastic thyroid carcinoma.
Han JM; Bae Kim W; Kim TY; Ryu JS; Gong G; Hong SJ; Kim JH; Oh YL; Jang HW; Kim SW; Chung JH; Shong YK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):459-64. PubMed ID: 22458627
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
37. Survival and prognostic factors of anaplastic thyroid carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
[TBL] [Abstract][Full Text] [Related]
38. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.
Haase J; Misiak D; Bauer M; Pazaitis N; Braun J; Pötschke R; Mensch A; Bell JL; Dralle H; Siebolts U; Wickenhauser C; Lorenz K; Hüttelmaier S
Mod Pathol; 2021 Jan; 34(1):32-41. PubMed ID: 32719445
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
40. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]